Medicine & Life Sciences
(R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine
19%
1,3-bis(2-hydroxy-5-trifluoromethylphenyl)urea
26%
1-(3,5-bis(trifluoromethyl)phenyl)-3-(4-bromo-2-(1H-tetrazol-5-yl)phenyl)thiourea
20%
1-(3,5-bis-trifluoromethylphenyl)-3-(2,4-dibromo-6-(1H-tetrazol-5-yl)phenyl)urea
18%
Action Potentials
64%
Adrenergic Receptors
15%
AP14145
15%
Apolipoproteins M
89%
Arteries
19%
Atherosclerosis
36%
Atrial Fibrillation
100%
Atrial Remodeling
19%
Atrioventricular Block
16%
Blood Vessels
18%
Brugada Syndrome
38%
Calcium-Activated Potassium Channels
40%
Cardiac Arrhythmias
65%
Cardiac Myocytes
36%
Connexin 43
26%
Connexins
19%
dofetilide
23%
Electrocardiography
45%
Endothelium
17%
Exome
19%
ezogabine
21%
Gain of Function Mutation
16%
Gap Junctions
25%
Genes
38%
Glucagon-Like Peptide 1
29%
Guinea Pigs
22%
Heart
71%
Heart Failure
28%
Heart Rate
28%
Horses
25%
Hypertension
16%
Ion Channels
46%
KCNQ1 Potassium Channel
24%
Kidney
22%
Kinetics
16%
Large-Conductance Calcium-Activated Potassium Channels
24%
Lipoproteins
15%
Long QT Syndrome
85%
Membrane Potentials
18%
Mesenteric Arteries
31%
Mortality
16%
Muscle Cells
17%
Mutation
59%
Myocardial Infarction
20%
Oocytes
34%
Pharmaceutical Preparations
21%
Pharmacology
27%
Phenotype
16%
Population
18%
Potassium
31%
Potassium Channels
52%
Proteins
25%
Romano-Ward Syndrome
17%
sertindole
21%
Small-Conductance Calcium-Activated Potassium Channels
28%
Smooth Muscle Myocytes
20%
Sodium
16%
Sodium Channels
20%
Sotalol
15%
sphingosine 1-phosphate
31%
Sudden Cardiac Death
21%
Syncope
17%
Torsades de Pointes
40%
Type 2 Diabetes Mellitus
15%
Uremia
21%
Vascular Smooth Muscle
15%
Vasodilation
25%
Voltage-Gated Potassium Channels
35%
Xenopus laevis
26%